Key Finding
All women who responded to therapeutic local anesthesia for vulvodynia remained completely symptom-free during a follow-up period averaging 7.9 years, supporting the theory that vulvodynia involves pelvic floor nerve dysfunction.
Researchers in Germany followed 45 women with severe chronic vulvar pain (vulvodynia) for nearly 8 years after they received therapeutic local anesthesia (TLA) treatments. Vulvodynia is a debilitating condition affecting 7-11% of women, causing chronic pain in the vulvar area that significantly impacts quality of life and sexual function. The women in this study had severe pain (averaging 7.9 on a 10-point scale) lasting an average of over 5 years before treatment. The results were remarkable: all women who initially responded to TLA remained pain-free during the entire follow-up period of 4.5 to 13 years, and two women who initially didn't respond also eventually became pain-free. The researchers found that certain factors made treatment less likely to succeed, including previous corticosteroid therapy, lichen sclerosus (a skin condition), history of trauma, recurrent bladder infections, depression, and use of psychotropic medications. Interestingly, factors like age, number of pregnancies, or hormonal status didn't affect outcomes. While this study focused on local anesthesia rather than acupuncture, the findings support the theory that vulvodynia involves nerve dysfunction in the pelvic floor. This is relevant for acupuncture patients because acupuncture also targets nerve function and has been used for various pelvic pain conditions. The study emphasizes that vulvodynia requires a comprehensive, holistic treatment approach addressing both physical and psychological factors. Women considering acupuncture for vulvodynia should seek a qualified practitioner experienced in treating pelvic pain conditions.
This prospective observational study evaluated long-term outcomes of therapeutic local anesthesia (TLA) in 45 women with severe chronic vulvodynia (NAS ≥6, median 7.9; duration ≥6 months, median 65.2 months). At follow-up averaging 7.9 years post-treatment (range 55-156 months), 38 patients were re-evaluated. All 32 original responders (defined as NAS ≤4 for ≥6 months) maintained symptom-free status, and 2 of 4 available non-responders converted to responders. Factors significantly associated with non-response included: number of previous physicians consulted, lichen sclerosus, prior trauma, recurrent cystitis, corticosteroid therapy, depression, psychotropic medication use, psychotherapy history, and lower BMI. Hormonal status, parity, cesarean sections, age, and gynecological surgeries showed no impact on outcomes. The sustained efficacy supports vulvodynia as a peripheral neuro-functional disorder involving pelvic floor nerve pathology. Clinical takeaway: A holistic treatment approach addressing both neuropathic and psychological components is essential for managing chronic vulvodynia.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Mechanical stimuli may reprogram neuroinflammation and reduce spinal sensitization by modulating microglial and astrocytic reactivity, inflammatory signaling pathways, and neuroimmune synaptic plasticity, providing a mechanistic basis for non-pharmacological pain relief.
📌 Chronic pain is maintained by maladaptive neuroimmune interactions, with preliminary human imaging and biofluid studies revealing glial activation and suggesting distinct immune endotypes that may guide targeted immunotherapy approaches.
📌 Combining electroacupuncture with conventional therapy achieved a 94.55% response rate and 60% reduction in inflammatory markers compared to 78.18% response rate and 32-37% inflammatory reduction with conventional therapy alone in women with chronic pelvic pain.